Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

EQVA ASA: Granting of share options

EQVASelskabsmeddelelse01.09.2026, 14.55
The Board of EQVA ASA (OSE: EQVA) ("EQVA" or the "Company") has approved the
award and allocation of 940,000 share options, at a strike price of NOK 3,16 per
share. The strike price is set in accordance with the approved annual incentive
scheme, based on the 20 days previous to the final resolution of the grant.

The following persons have been granted share options in the allocation:

Ingrid Due-Gundersen, Chair of the Board: 100,000 share options. Following the
grant, Due-Gundersen holds a total of 2,100,000 share options in the Company.

Hans Olav Lindal, Board member: 100,000 share options. Following the grant,
Lindal holds a total of 100,000 share options in the Company.

Gudmund Øvrehus, Board member: 100,000 share options. Following the grant,
Øvrehus holds a total of 200,000 share options in the Company.

Kari Markhus, Board member: 100,000 share options. Following the grant, Markhus
holds a total of 180,000 share options in the Company.

Olav Hilmar Koløy, Chief Executive Officer: 100,000 share options. Following the
grant, Koløy holds a total of 100,000 share options in the Company.

Daniel Hjertaker Molvik, Chief Financial Officer: 100,000 share options.
Following the grant, Molvik holds a total of 400,000 share options in the
Company.

Sverre Olav Handeland, General Counsel: 100,000 share options. Following the
grant, Handeland holds a total of 300,000 share options in the Company.

Ask Haukaas, Head of Strategy and Business Development: 100,000 share options.
Following the grant, Haukaas holds a total of 300,000 share options in the
Company.

Erik Høyvik, Business Developer: 100,000 share options. Following the grant,
Høyvik holds a total of 266,667 share options in the Company.

The award is in accordance with the approved annual incentive scheme.

The vesting periods for the share options are from 2027 to 2029 and the strike
price is adjusted in the following way:

- Exercise in January 2027: Basis Strike
- Exercise in January 2028: Basis Strike * 1.10
- Exercise in January 2029: Basis Strike * 1.21

See attachments for further details about the grant of options to each primary
insider.

Following the grant, the total number of outstanding options in Eqva are
3,373,334. The outstanding number of ordinary shares in EQVA ASA are 89 177 634.

For more information, please contact: Daniel Hjertaker Molvik, Chief Financial
Officer of EQVA ASA, daniel.molvik@eqva.no.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
ject to the disclosure requirements pursuant to section 5\
-12 of the Norwegian Securities Trading Act.\